Retatrutide 30mg
Retatrutide 30mg
Often called simply "reta" in research communities, retatrutide is a triple receptor agonist (GIP / GLP-1 / glucagon) currently in Phase 3 development — this is our most popular 20mg research vial.
Retatrutide 30mg is supplied as a lyophilised research material intended exclusively for laboratory research applications.
Each vial contains 30mg of lyophilised material in a sealed glass research vial and is supplied for research use only.
Product Information
Product: Retatrutide
Quantity: 30mg
Form: Lyophilised Powder
Appearance: White to off-white lyophilised cake
Container: Sealed glass research vial
Storage: Store refrigerated at 2–8°C before reconstitution.
Intended Use: Research Use Only.
Third-Party Lab Verification (COA)
Third-Party Lab Verification (COA) Independently tested by Vanguard Laboratory via Purity Analytics. Batch: 20260716L02RT3S30 · Reported: 02 Nov 2026 Purity (HPLC): 99.72% · Content: 30.30 mg · Solubility: Pass · Identity: Pass Verify online: https://verify.purityanalytics.com/coa/coa_3a65131b740f587935fae06bc09be728